Diets rich in dairy and wheat proteins reduce cholera infections

Researchers at the University of California, Riverside have discovered that diets high in casein from dairy and wheat gluten can slash cholera bacteria colonization in the gut by up to 100 times. The findings, from mouse studies, show these proteins disrupt a key bacterial weapon. Ansel Hsiao, the study's senior author, highlighted the surprising magnitude of the effect.

A new study led by Ansel Hsiao, an associate professor of microbiology and plant pathology at the University of California, Riverside, reveals how specific proteins in the diet can combat Vibrio cholerae, the bacterium behind cholera. Cholera causes severe diarrhea and can be fatal without prompt treatment, remaining a threat in areas with poor sanitation like parts of Asia and sub-Saharan Africa. The research, published in Cell Host & Microbe, tested various diets on infected mice: high-fat ones had minimal impact, while high-carbohydrate diets provided only slight protection. Diets rich in casein—the main protein in milk and cheese—and wheat gluten nearly eliminated bacterial colonization in the gut. Hsiao noted, 'I wasn't surprised that diet could affect the health of someone infected with the bacteria. But the magnitude of the effect surprised me.' He added, 'We saw up to 100-fold differences in the amount of cholera colonization as a function of diet alone.' The proteins work by suppressing the bacteria's type 6 secretion system (T6SS), a syringe-like structure used to inject toxins and outcompete other gut microbes. Without it, cholera cannot dominate the intestinal environment. Hsiao emphasized the potential as a low-cost alternative to antibiotics, which risk fostering resistance. 'Dietary strategies won't generate antibiotic resistance in the same way a drug might,' he said. The team plans further research on human microbiomes and other pathogens, with Hsiao suggesting broader protective benefits from improved diets.

ተያያዥ ጽሁፎች

Scientific illustration of a lab mouse with regenerating small intestine linked to cysteine-rich diet for MIT study news.
በ AI የተሰራ ምስል

MIT study links dietary cysteine to faster small-intestine repair in mice

በAI የተዘገበ በ AI የተሰራ ምስል እውነት ተፈትሸ

MIT researchers report that the amino acid cysteine, found in many protein-rich foods, can enhance the small intestine’s ability to regenerate after injury in mice by triggering an immune-to-stem-cell signaling cascade. The work, published in Nature, raises the possibility—still untested in people—that diet or supplementation could someday help ease some treatment-related intestinal damage during radiation or chemotherapy.

Researchers led by Helmholtz Munich report that some gut-dwelling bacteria — including strains not typically considered harmful — possess syringe-like molecular machinery that can deliver bacterial proteins into human cells, affecting immune and metabolic signaling. The work also links these bacterial “effector” genes to Crohn’s disease–associated microbiome patterns, though the authors say more studies are needed to determine how the mechanism influences disease.

በAI የተዘገበ

Research suggests that microbes in the gut and mouth could determine whether peanut allergies lead to mild or life-threatening responses. A study on mice and humans points to specific bacteria that might reduce anaphylaxis risks. Scientists propose probiotics as a potential treatment to lessen severe reactions.

Researchers at APC Microbiome Ireland at University College Cork report that early-life exposure to a high-fat, high-sugar diet altered feeding behavior and appetite-related brain pathways in mice into adulthood, even after the animals returned to a standard diet and normal body weight. The team also found that a specific Bifidobacterium strain and a prebiotic fiber mix helped mitigate some of these long-term effects.

በAI የተዘገበ

Researchers have developed a device that filters the protein galectin-3 from the blood, showing improved survival in rat and pig models of sepsis. The approach, tested by a team in China, reduced mortality compared to controls. Human trials are planned for 2027.

ይህ ድረ-ገጽ ኩኪዎችን ይጠቀማል

የእኛን ጣቢያ ለማሻሻል ለትንታኔ ኩኪዎችን እንጠቀማለን። የእኛን የሚስጥር ፖሊሲ አንብቡ የሚስጥር ፖሊሲ ለተጨማሪ መረጃ።
ውድቅ አድርግ